Clinical Trial Update: huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for huCART-meso plus VCN-01 in pancreatic cancer and serous ovarian cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Serous Ovarian Cancer

Drugs mentioned

• VCN-01
• huCART-meso

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Cancer, Serous Ovarian Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING